Current susceptibilities of staphylococci to glycopeptides determined as part of an international resistance surveillance programme [6]

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 1, 1998, Pages 119-121

  Jones, M E ^a   Jones, R N ^a   Sader, H ^a   Verhoef, J ^a   Acar, J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPEPTIDE; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; CANADA; COAGULASE NEGATIVE STAPHYLOCOCCUS; EUROPE; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SOUTH AMERICA; STAPHYLOCOCCUS; UNITED STATES;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; GLYCOPEPTIDES; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS; WORLD HEALTH;

EID: 0031819777     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.1.119     Document Type: Letter

References (6)